For instance, in June 2024, the Therapeutics Goods Administration (TGA) of Australian announced amendments to the Therapeutics Goods Regulations 1990 (Schedule 5, item 6) under which compounded GLP-1 RA products and medicines will no longer compounded by pharmacists and supplied to patients effective from October 1, 2024
Ozempic joint or muscle pain may be due to underlying health conditions, other medications, injection site pain, dehydration, or increased exercise
For example, a study designed to investigate the direct gene modulating effects of the peptide sequence itself, independent of copper delivery, might utilize apo-GHK in a copper-depleted culture medium
But pharmacovigilance databases tell a different story, one where 144 cases of anxiety have been reported among GLP-1 receptor agonist users